His laboratory focuses on fluoroquinolone action and resistance with M. tuberculosis and other bacteria, including approaches to slowing the enrichment and amplification of resistant bacterial subpopulations.
Karl Drlica
A principal investigator at the public health research institute center of the UMDNJ—New Jersey Medical School in Newark, NJ.
Contact information
- Karl A Drlica